Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Molar sodium lactate infusion for cerebral hemodynamics in severe aneurysmal subarachnoid hemorrhage
2021-000586-33Phase 3Terminated
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Sodium lactate in subarachnoid hemorrhage (SAH) (2 arms), sponsored by Centre Hospitalier Universitaire de Nice. Primary endpoints: Incidence of cerebral vasospasm and Angiographic vasospasm on 15 cerebral arterial segments. Started Jul 2021; status: terminated.
02
Drugs
Sodium lactate
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on 2021-000586-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000586-33.